MINNEAPOLIS--(BUSINESS WIRE)--AGA Medical Holdings, Inc. (AGA Medical) (NASDAQ:AGAM) has received regulatory approvals and licenses in China for its AMPLATZER® PFO Occluder and AMPLATZER® Multi-Fenestrated Septal Occluder “Cribriform.” The company has also received regulatory approval for its AMPLATZER® Vascular Plug II in China, and its license is pending. The company plans to make the products available through its distributor Abbott Vascular, a division of Abbott Laboratories, Inc.
